0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amyloid Peptides Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-3V4049
Home | Market Reports | Health| Aging & Geriatrics
Global Amyloid Peptides Market Insights Forecast to 2028
BUY CHAPTERS

Global Amyloid Peptides Market Research Report 2024

Code: QYRE-Auto-3V4049
Report
February 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Amyloid Peptides Market

Amyloid Peptides(Amyloid beta or Abeta) denotes peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients.The peptides derive from the amyloid precursor protein (APP), which is cleaved by beta secretase and gamma secretase to yield Aβ. Aβ molecules can aggregate to form flexible soluble oligomers which may exist in several forms.
The global Amyloid Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There has been a growing emphasis on biomarker research and the development of diagnostic tools for the early detection and monitoring of amyloid-related diseases, driving the demand for sensitive and specific assays capable of detecting and quantifying amyloid peptides in biological samples, facilitating early intervention and personalized treatment approaches.
This report aims to provide a comprehensive presentation of the global market for Amyloid Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyloid Peptides.

Report Scope

The Amyloid Peptides market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amyloid Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amyloid Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Amyloid Peptides Market Report

Report Metric Details
Report Name Amyloid Peptides Market
Segment by Type
  • Beta-Amyloid Mouse
  • Beta-Amyloid Rat
  • Beta-Amyloid Human
Segment by Application
  • Alzheimer's Disease Research
  • Cancer Research
  • Lewy Body Dementia Research
  • Inclusion Body Myositis Research
  • Cerebral Amyloid Angiopathy Research
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company rPeptide, AnaSpec, Inc, Genscript, BioLegend, NovoPro Inc., Bio-Synthesis, AmideBio, Cambridge Research Biochemicals, Bachem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Amyloid Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Amyloid Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Amyloid Peptides Market report?

Ans: The main players in the Amyloid Peptides Market are rPeptide, AnaSpec, Inc, Genscript, BioLegend, NovoPro Inc., Bio-Synthesis, AmideBio, Cambridge Research Biochemicals, Bachem

What are the Application segmentation covered in the Amyloid Peptides Market report?

Ans: The Applications covered in the Amyloid Peptides Market report are Alzheimer's Disease Research, Cancer Research, Lewy Body Dementia Research, Inclusion Body Myositis Research, Cerebral Amyloid Angiopathy Research, Others

What are the Type segmentation covered in the Amyloid Peptides Market report?

Ans: The Types covered in the Amyloid Peptides Market report are Beta-Amyloid Mouse, Beta-Amyloid Rat, Beta-Amyloid Human

1 Amyloid Peptides Market Overview
1.1 Product Overview and Scope of Amyloid Peptides
1.2 Amyloid Peptides Segment by Type
1.2.1 Global Amyloid Peptides Market Value Comparison by Type (2024-2030)
1.2.2 Beta-Amyloid Mouse
1.2.3 Beta-Amyloid Rat
1.2.4 Beta-Amyloid Human
1.3 Amyloid Peptides Segment by Application
1.3.1 Global Amyloid Peptides Market Value by Application: (2024-2030)
1.3.2 Alzheimer's Disease Research
1.3.3 Cancer Research
1.3.4 Lewy Body Dementia Research
1.3.5 Inclusion Body Myositis Research
1.3.6 Cerebral Amyloid Angiopathy Research
1.3.7 Others
1.4 Global Amyloid Peptides Market Size Estimates and Forecasts
1.4.1 Global Amyloid Peptides Revenue 2019-2030
1.4.2 Global Amyloid Peptides Sales 2019-2030
1.4.3 Global Amyloid Peptides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amyloid Peptides Market Competition by Manufacturers
2.1 Global Amyloid Peptides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amyloid Peptides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amyloid Peptides Average Price by Manufacturers (2019-2024)
2.4 Global Amyloid Peptides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amyloid Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amyloid Peptides, Product Type & Application
2.7 Amyloid Peptides Market Competitive Situation and Trends
2.7.1 Amyloid Peptides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amyloid Peptides Players Market Share by Revenue
2.7.3 Global Amyloid Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amyloid Peptides Retrospective Market Scenario by Region
3.1 Global Amyloid Peptides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amyloid Peptides Global Amyloid Peptides Sales by Region: 2019-2030
3.2.1 Global Amyloid Peptides Sales by Region: 2019-2024
3.2.2 Global Amyloid Peptides Sales by Region: 2025-2030
3.3 Global Amyloid Peptides Global Amyloid Peptides Revenue by Region: 2019-2030
3.3.1 Global Amyloid Peptides Revenue by Region: 2019-2024
3.3.2 Global Amyloid Peptides Revenue by Region: 2025-2030
3.4 North America Amyloid Peptides Market Facts & Figures by Country
3.4.1 North America Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amyloid Peptides Sales by Country (2019-2030)
3.4.3 North America Amyloid Peptides Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amyloid Peptides Market Facts & Figures by Country
3.5.1 Europe Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amyloid Peptides Sales by Country (2019-2030)
3.5.3 Europe Amyloid Peptides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amyloid Peptides Market Facts & Figures by Country
3.6.1 Asia Pacific Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amyloid Peptides Sales by Country (2019-2030)
3.6.3 Asia Pacific Amyloid Peptides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amyloid Peptides Market Facts & Figures by Country
3.7.1 Latin America Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amyloid Peptides Sales by Country (2019-2030)
3.7.3 Latin America Amyloid Peptides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amyloid Peptides Market Facts & Figures by Country
3.8.1 Middle East and Africa Amyloid Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amyloid Peptides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amyloid Peptides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amyloid Peptides Sales by Type (2019-2030)
4.1.1 Global Amyloid Peptides Sales by Type (2019-2024)
4.1.2 Global Amyloid Peptides Sales by Type (2025-2030)
4.1.3 Global Amyloid Peptides Sales Market Share by Type (2019-2030)
4.2 Global Amyloid Peptides Revenue by Type (2019-2030)
4.2.1 Global Amyloid Peptides Revenue by Type (2019-2024)
4.2.2 Global Amyloid Peptides Revenue by Type (2025-2030)
4.2.3 Global Amyloid Peptides Revenue Market Share by Type (2019-2030)
4.3 Global Amyloid Peptides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amyloid Peptides Sales by Application (2019-2030)
5.1.1 Global Amyloid Peptides Sales by Application (2019-2024)
5.1.2 Global Amyloid Peptides Sales by Application (2025-2030)
5.1.3 Global Amyloid Peptides Sales Market Share by Application (2019-2030)
5.2 Global Amyloid Peptides Revenue by Application (2019-2030)
5.2.1 Global Amyloid Peptides Revenue by Application (2019-2024)
5.2.2 Global Amyloid Peptides Revenue by Application (2025-2030)
5.2.3 Global Amyloid Peptides Revenue Market Share by Application (2019-2030)
5.3 Global Amyloid Peptides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 rPeptide
6.1.1 rPeptide Corporation Information
6.1.2 rPeptide Description and Business Overview
6.1.3 rPeptide Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 rPeptide Amyloid Peptides Product Portfolio
6.1.5 rPeptide Recent Developments/Updates
6.2 AnaSpec, Inc
6.2.1 AnaSpec, Inc Corporation Information
6.2.2 AnaSpec, Inc Description and Business Overview
6.2.3 AnaSpec, Inc Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AnaSpec, Inc Amyloid Peptides Product Portfolio
6.2.5 AnaSpec, Inc Recent Developments/Updates
6.3 Genscript
6.3.1 Genscript Corporation Information
6.3.2 Genscript Description and Business Overview
6.3.3 Genscript Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Genscript Amyloid Peptides Product Portfolio
6.3.5 Genscript Recent Developments/Updates
6.4 BioLegend
6.4.1 BioLegend Corporation Information
6.4.2 BioLegend Description and Business Overview
6.4.3 BioLegend Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioLegend Amyloid Peptides Product Portfolio
6.4.5 BioLegend Recent Developments/Updates
6.5 NovoPro Inc.
6.5.1 NovoPro Inc. Corporation Information
6.5.2 NovoPro Inc. Description and Business Overview
6.5.3 NovoPro Inc. Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 NovoPro Inc. Amyloid Peptides Product Portfolio
6.5.5 NovoPro Inc. Recent Developments/Updates
6.6 Bio-Synthesis
6.6.1 Bio-Synthesis Corporation Information
6.6.2 Bio-Synthesis Description and Business Overview
6.6.3 Bio-Synthesis Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bio-Synthesis Amyloid Peptides Product Portfolio
6.6.5 Bio-Synthesis Recent Developments/Updates
6.7 AmideBio
6.6.1 AmideBio Corporation Information
6.6.2 AmideBio Description and Business Overview
6.6.3 AmideBio Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AmideBio Amyloid Peptides Product Portfolio
6.7.5 AmideBio Recent Developments/Updates
6.8 Cambridge Research Biochemicals
6.8.1 Cambridge Research Biochemicals Corporation Information
6.8.2 Cambridge Research Biochemicals Description and Business Overview
6.8.3 Cambridge Research Biochemicals Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cambridge Research Biochemicals Amyloid Peptides Product Portfolio
6.8.5 Cambridge Research Biochemicals Recent Developments/Updates
6.9 Bachem
6.9.1 Bachem Corporation Information
6.9.2 Bachem Description and Business Overview
6.9.3 Bachem Amyloid Peptides Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bachem Amyloid Peptides Product Portfolio
6.9.5 Bachem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amyloid Peptides Industry Chain Analysis
7.2 Amyloid Peptides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amyloid Peptides Production Mode & Process
7.4 Amyloid Peptides Sales and Marketing
7.4.1 Amyloid Peptides Sales Channels
7.4.2 Amyloid Peptides Distributors
7.5 Amyloid Peptides Customers
8 Amyloid Peptides Market Dynamics
8.1 Amyloid Peptides Industry Trends
8.2 Amyloid Peptides Market Drivers
8.3 Amyloid Peptides Market Challenges
8.4 Amyloid Peptides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Amyloid Peptides Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Amyloid Peptides Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Amyloid Peptides Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Amyloid Peptides Sales (g) of Key Manufacturers (2019-2024)
    Table 5. Global Amyloid Peptides Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Amyloid Peptides Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Amyloid Peptides Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Amyloid Peptides Average Price (USD/g) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Amyloid Peptides, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Amyloid Peptides, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Amyloid Peptides, Product Type & Application
    Table 12. Global Key Manufacturers of Amyloid Peptides, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Amyloid Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyloid Peptides as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Amyloid Peptides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Amyloid Peptides Sales by Region (2019-2024) & (g)
    Table 18. Global Amyloid Peptides Sales Market Share by Region (2019-2024)
    Table 19. Global Amyloid Peptides Sales by Region (2025-2030) & (g)
    Table 20. Global Amyloid Peptides Sales Market Share by Region (2025-2030)
    Table 21. Global Amyloid Peptides Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Amyloid Peptides Revenue Market Share by Region (2019-2024)
    Table 23. Global Amyloid Peptides Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Amyloid Peptides Revenue Market Share by Region (2025-2030)
    Table 25. North America Amyloid Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Amyloid Peptides Sales by Country (2019-2024) & (g)
    Table 27. North America Amyloid Peptides Sales by Country (2025-2030) & (g)
    Table 28. North America Amyloid Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Amyloid Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Amyloid Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Amyloid Peptides Sales by Country (2019-2024) & (g)
    Table 32. Europe Amyloid Peptides Sales by Country (2025-2030) & (g)
    Table 33. Europe Amyloid Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Amyloid Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Amyloid Peptides Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Amyloid Peptides Sales by Region (2019-2024) & (g)
    Table 37. Asia Pacific Amyloid Peptides Sales by Region (2025-2030) & (g)
    Table 38. Asia Pacific Amyloid Peptides Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Amyloid Peptides Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Amyloid Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Amyloid Peptides Sales by Country (2019-2024) & (g)
    Table 42. Latin America Amyloid Peptides Sales by Country (2025-2030) & (g)
    Table 43. Latin America Amyloid Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Amyloid Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Amyloid Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Amyloid Peptides Sales by Country (2019-2024) & (g)
    Table 47. Middle East & Africa Amyloid Peptides Sales by Country (2025-2030) & (g)
    Table 48. Middle East & Africa Amyloid Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Amyloid Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Amyloid Peptides Sales (g) by Type (2019-2024)
    Table 51. Global Amyloid Peptides Sales (g) by Type (2025-2030)
    Table 52. Global Amyloid Peptides Sales Market Share by Type (2019-2024)
    Table 53. Global Amyloid Peptides Sales Market Share by Type (2025-2030)
    Table 54. Global Amyloid Peptides Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Amyloid Peptides Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Amyloid Peptides Revenue Market Share by Type (2019-2024)
    Table 57. Global Amyloid Peptides Revenue Market Share by Type (2025-2030)
    Table 58. Global Amyloid Peptides Price (USD/g) by Type (2019-2024)
    Table 59. Global Amyloid Peptides Price (USD/g) by Type (2025-2030)
    Table 60. Global Amyloid Peptides Sales (g) by Application (2019-2024)
    Table 61. Global Amyloid Peptides Sales (g) by Application (2025-2030)
    Table 62. Global Amyloid Peptides Sales Market Share by Application (2019-2024)
    Table 63. Global Amyloid Peptides Sales Market Share by Application (2025-2030)
    Table 64. Global Amyloid Peptides Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Amyloid Peptides Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Amyloid Peptides Revenue Market Share by Application (2019-2024)
    Table 67. Global Amyloid Peptides Revenue Market Share by Application (2025-2030)
    Table 68. Global Amyloid Peptides Price (USD/g) by Application (2019-2024)
    Table 69. Global Amyloid Peptides Price (USD/g) by Application (2025-2030)
    Table 70. rPeptide Corporation Information
    Table 71. rPeptide Description and Business Overview
    Table 72. rPeptide Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 73. rPeptide Amyloid Peptides Product
    Table 74. rPeptide Recent Developments/Updates
    Table 75. AnaSpec, Inc Corporation Information
    Table 76. AnaSpec, Inc Description and Business Overview
    Table 77. AnaSpec, Inc Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 78. AnaSpec, Inc Amyloid Peptides Product
    Table 79. AnaSpec, Inc Recent Developments/Updates
    Table 80. Genscript Corporation Information
    Table 81. Genscript Description and Business Overview
    Table 82. Genscript Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 83. Genscript Amyloid Peptides Product
    Table 84. Genscript Recent Developments/Updates
    Table 85. BioLegend Corporation Information
    Table 86. BioLegend Description and Business Overview
    Table 87. BioLegend Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 88. BioLegend Amyloid Peptides Product
    Table 89. BioLegend Recent Developments/Updates
    Table 90. NovoPro Inc. Corporation Information
    Table 91. NovoPro Inc. Description and Business Overview
    Table 92. NovoPro Inc. Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 93. NovoPro Inc. Amyloid Peptides Product
    Table 94. NovoPro Inc. Recent Developments/Updates
    Table 95. Bio-Synthesis Corporation Information
    Table 96. Bio-Synthesis Description and Business Overview
    Table 97. Bio-Synthesis Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 98. Bio-Synthesis Amyloid Peptides Product
    Table 99. Bio-Synthesis Recent Developments/Updates
    Table 100. AmideBio Corporation Information
    Table 101. AmideBio Description and Business Overview
    Table 102. AmideBio Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 103. AmideBio Amyloid Peptides Product
    Table 104. AmideBio Recent Developments/Updates
    Table 105. Cambridge Research Biochemicals Corporation Information
    Table 106. Cambridge Research Biochemicals Description and Business Overview
    Table 107. Cambridge Research Biochemicals Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 108. Cambridge Research Biochemicals Amyloid Peptides Product
    Table 109. Cambridge Research Biochemicals Recent Developments/Updates
    Table 110. Bachem Corporation Information
    Table 111. Bachem Description and Business Overview
    Table 112. Bachem Amyloid Peptides Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 113. Bachem Amyloid Peptides Product
    Table 114. Bachem Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Amyloid Peptides Distributors List
    Table 118. Amyloid Peptides Customers List
    Table 119. Amyloid Peptides Market Trends
    Table 120. Amyloid Peptides Market Drivers
    Table 121. Amyloid Peptides Market Challenges
    Table 122. Amyloid Peptides Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Amyloid Peptides
    Figure 2. Global Amyloid Peptides Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Amyloid Peptides Market Share by Type in 2023 & 2030
    Figure 4. Beta-Amyloid Mouse Product Picture
    Figure 5. Beta-Amyloid Rat Product Picture
    Figure 6. Beta-Amyloid Human Product Picture
    Figure 7. Global Amyloid Peptides Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Amyloid Peptides Market Share by Application in 2023 & 2030
    Figure 9. Alzheimer's Disease Research
    Figure 10. Cancer Research
    Figure 11. Lewy Body Dementia Research
    Figure 12. Inclusion Body Myositis Research
    Figure 13. Cerebral Amyloid Angiopathy Research
    Figure 14. Others
    Figure 15. Global Amyloid Peptides Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Amyloid Peptides Market Size (2019-2030) & (US$ Million)
    Figure 17. Global Amyloid Peptides Sales (2019-2030) & (g)
    Figure 18. Global Amyloid Peptides Average Price (USD/g) & (2019-2030)
    Figure 19. Amyloid Peptides Report Years Considered
    Figure 20. Amyloid Peptides Sales Share by Manufacturers in 2023
    Figure 21. Global Amyloid Peptides Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest Amyloid Peptides Players: Market Share by Revenue in 2023
    Figure 23. Amyloid Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global Amyloid Peptides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America Amyloid Peptides Sales Market Share by Country (2019-2030)
    Figure 26. North America Amyloid Peptides Revenue Market Share by Country (2019-2030)
    Figure 27. U.S. Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe Amyloid Peptides Sales Market Share by Country (2019-2030)
    Figure 30. Europe Amyloid Peptides Revenue Market Share by Country (2019-2030)
    Figure 31. Germany Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Amyloid Peptides Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific Amyloid Peptides Revenue Market Share by Region (2019-2030)
    Figure 38. China Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Taiwan Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Indonesia Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Thailand Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Malaysia Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Philippines Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Latin America Amyloid Peptides Sales Market Share by Country (2019-2030)
    Figure 49. Latin America Amyloid Peptides Revenue Market Share by Country (2019-2030)
    Figure 50. Mexico Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Brazil Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Argentina Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Middle East & Africa Amyloid Peptides Sales Market Share by Country (2019-2030)
    Figure 54. Middle East & Africa Amyloid Peptides Revenue Market Share by Country (2019-2030)
    Figure 55. Turkey Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. U.A.E Amyloid Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. Global Sales Market Share of Amyloid Peptides by Type (2019-2030)
    Figure 59. Global Revenue Market Share of Amyloid Peptides by Type (2019-2030)
    Figure 60. Global Amyloid Peptides Price (USD/g) by Type (2019-2030)
    Figure 61. Global Sales Market Share of Amyloid Peptides by Application (2019-2030)
    Figure 62. Global Revenue Market Share of Amyloid Peptides by Application (2019-2030)
    Figure 63. Global Amyloid Peptides Price (USD/g) by Application (2019-2030)
    Figure 64. Amyloid Peptides Value Chain
    Figure 65. Amyloid Peptides Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS